Rossari Biotech Ltd.

NSE: ROSSARI | BSE: 543213 | ISIN: INE02A801020 | Industry: Specialty Chemicals
| Mid-range Performer
695.5000 -6.25 (-0.89%)
NSE Jul 30, 2025 15:31 PM
Volume: 27,968
 

695.50
-0.89%
ICICI Securities Limited
Rossari Biotech’s (Rossari) Q2FY24 HPPC revenue (+21% YoY) was led by a volume push which has hurt prices and margins. Despite rise in utilisation from 50-55% to >75%, EBITDA margin dipped 100bp QoQ to 13.1%. It has chosen to play volume game for FY24 to drive utilisation, and expects to improve margins as plant utilisations stabilise at higher levels, which in our view can cap return ratio in near term.
Deven Choksey released a Buy report for Rossari Biotech Ltd. with a price target of 860.0 on 25 Jul, 2025.
More from Rossari Biotech Ltd.
Recommended